Friday, August 1, 2014

Second Question of the Day August 1, 2014 Do compounding pharmacies who focus on and make a large amount of money from compounded pain creams think they are on touchable since the FDA is focused on outsourcing facilities? Should the FDA also ramp up its enforcement action against those" manufacturer" compounded pain creams? Should this be something DOJ/FBI/DEA should focus on prosecuting and recovering ill gotten gains?


No comments: